Cleocin Phosphate (clindamycin phosphate) NDC 0009-3051

NDC codes

FDA NDC Directory

Product NDC (as listed)0009-3051Labeler and product segments. Claims need a package NDC.

Product NDC at billing width00009-3051Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
0009-3051-02	00009305102	25 VIAL in 1 CARTON (0009-3051-02) / 2 mL in 1 VIAL (0009-3051-01)Marketed from Nov 18, 2019

How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Cleocin Phosphate
Generic name (nonproprietary): clindamycin phosphate
Active ingredients: Clindamycin phosphate — 150 mg/mL
Dosage form: Injection, Solution
Route: Intramuscular, Intravenous
Labeler: Pharmacia & Upjohn Company LLC
Product type: Prescription drug
Marketing category: NDA — New Drug ApplicationApplication NDA 050441
Marketing start: Nov 18, 2019
Marketing end: Oct 31, 2026
Other FDA classes: Decreased Sebaceous Gland Activity (Physiologic effect)Lincosamides (Chemical structure)Neuromuscular Blockade (Physiologic effect)
Identifiers: Product ID 0009-3051_8d0dac99-6ec9-4648-8ae1-0cc2894d56cfSPL ID 8d0dac99-6ec9-4648-8ae1-0cc2894d56cfSPL set ID a0a2eff7-b7de-42fe-8e5a-0cfbed38bb4bRxCUI 1737244, 1737245, 1737578, 1737579, 1737581, 1737582UNII EH6D7113I8
Pharmacologic class: Lincosamide Antibacterial

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N400009305102 followed by a unit qualifier and the quantity

Package 00009-3051-02. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective May 13, 2026. This label includes a boxed warning.

Indications (excerpt from the label)

INDICATIONS AND USAGE CLEOCIN PHOSPHATE products are indicated in the treatment of serious infections caused by susceptible anaerobic bacteria. CLEOCIN PHOSPHATE products are also indicated in the treatment of serious infections due to susceptible strains of streptococci, pneumococci, and staphylococci. Its use should be reserved for penicillin-allergic patients or other patients for whom, in the judgment of the physician, a penicillin is inappropriate. Because of the risk of antibacterial drug-associated pseudomembranous colitis, as described in the BOXED WARNING , before selecting clindamycin the physician should consider the nature of the infection and the suitability of less toxic altern…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under NDA 050441

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under NDA 050441
Product	Strength	Form · route	Labeler	Product NDC
Cleocin Phosphateclindamycin phosphate	Clindamycin phosphate 150 mg/mL	Injection, SolutionIntramuscular, Intravenous	Medical Purchasing Solutions, LLC	71872-7197
Cleocin Phosphateclindamycin phosphate	Clindamycin phosphate 150 mg/mL	Injection, SolutionIntramuscular, Intravenous	Medical Purchasing Solutions, LLC	71872-7165
Cleocin Phosphateclindamycin phosphate	Clindamycin phosphate 150 mg/mL	Injection, SolutionIntramuscular, Intravenous	Pharmacia & Upjohn Company LLC	0009-0870
Cleocin Phosphateclindamycin phosphate	Clindamycin phosphate 150 mg/mL	Injection, SolutionIntramuscular, Intravenous	Henry Schein, Inc.	0404-9837
Cleocin Phosphateclindamycin phosphate	Clindamycin phosphate 150 mg/mL	Injection, SolutionIntramuscular, Intravenous	Pharmacia & Upjohn Company LLC	0009-0775
Cleocin Phosphateclindamycin phosphate	Clindamycin phosphate 150 mg/mL	Injection, SolutionIntramuscular, Intravenous	Medical Purchasing Solutions, LLC	71872-7200
Cleocin Phosphateclindamycin phosphate	Clindamycin phosphate 150 mg/mL	Injection, SolutionIntramuscular, Intravenous	Medical Purchasing Solutions, LLC	71872-7324
Cleocin Phosphateclindamycin phosphate	Clindamycin phosphate 150 mg/mL	Injection, SolutionIntramuscular, Intravenous	Pharmacia & Upjohn Company LLC	0009-5095
Cleocin Phosphateclindamycin phosphate	Clindamycin phosphate 150 mg/mL	Injection, SolutionIntramuscular, Intravenous	Pharmacia & Upjohn Company LLC	0009-0902
Cleocin Phosphateclindamycin phosphate	Clindamycin phosphate 150 mg/mL	Injection, SolutionIntramuscular, Intravenous	ProPharma Distribution	84549-775
Cleocin Phosphateclindamycin phosphate	Clindamycin phosphate 150 mg/mL	Injection, SolutionIntramuscular, Intravenous	Pharmacia & Upjohn Company LLC	0009-4073